Skip to main content
Process Advancing Medicine
  • Dublin
  • Boston
  • Worldwide

How to access differentiated API particle populations through Continuous Technologies

Click Image to Open in New Tab

Background:

For the synthesis and crystallization of APIs the application of multistage Mixed Suspension Mixed Product Removal Crystallizers (MSMPRCs) can be beneficial in addressing common problems encountered in batch production. The work conducted here focuses on two case studies concerning the combination of wet milling with multistage (MSMPRCs) to improve the physical properties of the respective APIs. 

1st Case Study: Standard Batch Process

Click Image to Open in New Tab

Limitations of batch:

• Particles exhibit thin needle morphology.•Changing various operating conditions yielded no significant results and so continuous crystallization was employed to try to improve particle aspect ratio.

Continuous Crystallization Setup

Click Image to Open in New Tab

Various challenges were met when performing the cooling crystallization in the multistage MSMPRC such as crystallization in the feed lines due to temperature drops between feed tanks and crystallizers. This was circumvented by employing heat exchangers on the feed lines.

Kinetic Limitations

Click Image to Open in New Tab

Issues encountered:

• Steady state was not reached after days of operation as the system does not retain consistent particle population•Level of nucleation not sufficient to maintain a set population of particles in the crystallizer.

Effect of Wet Milling

Benefits of in situ wet milling:

• Accelerates the nucleation rate due to increased turbulence within the crystallizer.•Enables particle attrition which helps to improve the particle aspect ratio.

Click Image to Open in New Tab

Improvement in Final Product

Improvement in final product assessed through examination of the aspect ratio of the particles via microscope.

Click Image to Open in New Tab

2nd Case Study: Standard Batch Process

Issues with standard batch process:

• Accessible particle size well in excess of formulation specification of50 < D50 [um] < 100•Forecast for API demand exceeded free batch plant capacity for manufacture.

Click Image to Open in New Tab

Continuous Crystallization Setup

Continuous cooling crystallization performed in cascaded MSMPRCs. In the absence of wet milling, the crystallization ran smoothly and steady-state was attained readily. 

Click Image to Open in New Tab

Kinetic Limitations

• Minimum particle size achievable based on the kinetics of the system

• Particle size could only be reduced to a D50 of 290um

• In situ wet milling required to deliver desired D50 size specification of 50-100µm      

Click Image to Open in New Tab

Optimized Process and Final Product

• Operating the two-stage MSMPRC with a first stage temperature of 18°C and a second stage temperature of 15°C with 5 minute residence times in each stage and a mill speed 16000rpm enabled sustained operation

.• Milling in stage 2 circumvented fouling issues and a product with a D50 of approximately 75µm was isolated

Click Image to Open in New Tab

 Conclusions

• Robust platforms combining cascaded MSMPRCs and wet milling were developed for the production of two APIs

• The particle aspect ratio was improved significantly in case study 1 through use of the developed platform

• The particle size of the product in case study 2 met the formulation requirements and the production rate was also increased through continuous manufacturing